Kaleo Release: Pharma Announces U.S. Availability And Pricing To Patients Of AUVI-Q (Epinephrine Injection, USP) Auto-Injector, For Life-Threatening Allergic Reactions Post author:Sam Post published:January 18, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like FDA Greenlights New Treatment for Multi-Drug Resistant HIV-1 March 6, 2018 Novartis AG Ordered to Hand Over 80,000 Records of `Sham' Events for Doctors March 30, 2017 Deal Spree Continues as Allergan Inks $2.47 Billion Deal for This Bay Area Biotech February 12, 2017